Scarica l'app Stockscreener
310.07
1.49%
4.56
Dopo l'orario di chiusura:
310.07
Precedente Chiudi:
$305.51
Aprire:
$307.59
Volume 24 ore:
326.89K
Relative Volume:
0.70
Capitalizzazione di mercato:
$8.64B
Reddito:
$7.46M
Utile/perdita netta:
$-326.53M
Rapporto P/E:
-23.17
EPS:
-13.3803
Flusso di cassa netto:
$-282.53M
1 W Prestazione:
+4.82%
1M Prestazione:
-2.65%
6M Prestazione:
+2.22%
1 anno Prestazione:
+506.91%
Intervallo 1D:
$301.40
$313.06
Intervallo di 1 settimana:
$287.94
$313.06
Portata 52W:
$37.19
$366.52
Praxis Precision Medicines Inc Stock (PRAX) Company Profile
Nome
Praxis Precision Medicines Inc
Settore
Industria
Telefono
617-300-8460
Indirizzo
99 HIGH STREET, 30TH FLOOR, BOSTON
Compare PRAX vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRAX
Praxis Precision Medicines Inc
|
310.07 | 8.80B | 7.46M | -326.53M | -282.53M | -13.38 |
VRTX
Vertex Pharmaceuticals Inc
|
478.70 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
760.66 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
844.50 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
193.46 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
323.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-07-13 | Iniziato | Goldman | Buy |
| 2026-06-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-04-10 | Iniziato | Raymond James | Strong Buy |
| 2026-02-24 | Iniziato | Wolfe Research | Outperform |
| 2026-02-02 | Iniziato | Wells Fargo | Equal Weight |
| 2025-12-15 | Reiterato | Oppenheimer | Outperform |
| 2025-11-19 | Iniziato | BTIG Research | Buy |
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-05-07 | Iniziato | Chardan Capital Markets | Buy |
| 2025-03-03 | Reiterato | H.C. Wainwright | Buy |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-08-05 | Iniziato | Oppenheimer | Outperform |
| 2024-06-24 | Iniziato | Needham | Buy |
| 2024-06-18 | Iniziato | Guggenheim | Buy |
| 2024-05-01 | Iniziato | Robert W. Baird | Outperform |
| 2023-09-19 | Iniziato | Truist | Buy |
| 2022-06-06 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-12-16 | Iniziato | H.C. Wainwright | Buy |
| 2021-08-26 | Iniziato | BofA Securities | Buy |
| 2021-04-26 | Iniziato | William Blair | Outperform |
| 2020-11-11 | Iniziato | Wedbush | Outperform |
| 2020-11-10 | Iniziato | Cowen | Outperform |
| 2020-11-10 | Iniziato | Evercore ISI | Outperform |
| 2020-11-10 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Praxis Precision Medicines Inc Borsa (PRAX) Ultime notizie
Praxis Precision Medicines Inc (PRAX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Praxis Precision Medicines Inc (PRAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Orbimed Advisors LLC Raises Position in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Praxis Precision Medicines Inc (PRAX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
SummitTX Capital L.P. Sells 4,791 Shares of Praxis Precision Medicines, Inc. $PRAX - MarketBeat
TradingKey - TradingKey
PRAX|Praxis Precision Medicines Inc|Price:325.300|Chg%:+2.900 - TradingKey
Praxis Precision Medicines Inc (PRAX) Institutional Confidence - TradingKey
Praxis Precision Medicines Inc (PRAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Swiss National Bank Acquires 6,200 Shares of Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Fifth Third Bancorp Acquires New Holdings in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Allspring Global Investments Holdings LLC Grows Stake in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Praxis Precision Shares Rally On Price Target Hikes: Analyst Sees Upside As High As 100% For Stock - Stocktwits
California Public Employees Retirement System Takes $13.58 Million Position in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Affinity Asset Advisors LLC Has $54.77 Million Position in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Praxis Precision Medicines, Inc. Revenue Breakdown – NASDAQ:PRAX - TradingView
Praxis Precision Medicines Inc (PRAX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Understanding the Setup: (PRAX) and Scalable Risk - Stock Traders Daily
ETFs Investing in Praxis Precision Medicines, Inc. Stocks - TradingView
Praxis Precision Medicines: Priced For Half Of What I Think It's Worth (NASDAQ:PRAX) - Seeking Alpha
Praxis Precision Medicines (PRAX) Bank of America Global Healthcare Conference 2026 summary - Quartr
PRAX stock trades around recent lows as Praxis Precision Medicines updates pipeline and cash runway - AD HOC NEWS
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Praxis Precision Medicines (PRAX) Enters Into Licensing and Research Collaboration With Remagine Labs - Yahoo Finance
Analysts Are Bullish on Top Healthcare Stocks: Praxis Precision Medicines (PRAX), Sino Biopharmaceutical (SBMFF) - The Globe and Mail
Praxis Precision Medicines (NASDAQ:PRAX) Upgraded by The Goldman Sachs Group to "Strong-Buy" Rating - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Piper Sandler reiterates Praxis Precision Medicines stock rating By Investing.com - Investing.com Nigeria
PRAX Initiates Coverage On Goldman Sachs -- Rating Set to Buy - GuruFocus
Piper Sandler reiterates Praxis Precision Medicines stock rating - Investing.com
Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $1,200 - Moomoo
Goldman Sachs initiates Praxis Precision Medicines stock coverage with buy rating - Investing.com
Candriam S.C.A. Has $20.50 Million Position in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
RBC Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $449 - Moomoo
Praxis Precision Medicines Seen Having Greater Commercial Upside for Relutrigine, RBC Says - Moomoo
Praxis Precision Medicines explores neurology pipeline as Nasdaq-listed biotech refines its focus - Ad Hoc News
Form 4 Praxis Precision Medicines Inc For: 8 July By Investing.com - Investing.com Nigeria
Praxis Precision Medicines Inc. (PRAX) Q1 2026 Earnings: Surprise Beat on EPS as Clinical Pipeline AdvancesRevenue Miss Report - dars.gov.et
Praxis (PRAX) CEO Marcio Souza gifts 23,121 shares, retains 56,495 - Stock Titan
Praxis Precision (PRAX) Partners with Remagine Labs for Innovati - GuruFocus
Praxis Precision Medicines Partners with Remagine Labs to Develop Innovative Transdermal Patch for Ulixacaltamide Delivery in Essential Tremor – Minichart - Minichart
Praxis (PRAX) teams with Remagine Labs on transdermal ulixacaltamide for essential tremor - Stock Titan
Praxis Precision Medicines and Remagine Labs Announce Strategic Collaboration to Develop Transdermal Ulixacaltamide for Essential Tremor - Investing News Network
Praxis bets on skin patch for essential tremor drug - Stock Titan
S&P 500 Futures Climb In Premarket Trading; Praxis Precision Meds, IREN Lead - Moomoo
S&P 500 Futures Climb in Premarket Trading; Praxis Precision Meds, IREN Lead - Barron's
If You Invested $1,000 in Praxis Precision Medicines, Inc. (PRAX) - Stock Titan
PRAX stock. Praxis Precision Medicines holds the spotlight on thin news - Ad-hoc-news.de
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Praxis Precision (NASDAQ: PRAX) replaces EY with KPMG as auditor - Stock Titan
Price to sales forward of Praxis Precision Medicines, Inc. – NASDAQ:PRAX - TradingView
Praxis Precision Medicines Inc Azioni (PRAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Praxis Precision Medicines Inc Azioni (PRAX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DeSimone Jill | Director |
Jun 24 '26 |
Sale |
311.32 |
11,600 |
3,611,335 |
2,337 |
0.98%
1.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):